{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T19:41:54Z","timestamp":1794944514915,"version":"4.9.1"},"reference-count":50,"publisher":"FapUNIFESP (SciELO)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Braz J Med Biol Res"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1590\/s0100-879x2006000400001","type":"journal-article","created":{"date-parts":[[2006,4,17]],"date-time":"2006-04-17T19:33:22Z","timestamp":1145302402000},"page":"421-429","source":"Crossref","is-referenced-by-count":292,"title":["Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug"],"prefix":"10.1590","volume":"39","author":[{"given":"A.W.","family":"Zuardi","sequence":"first","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.S.","family":"Crippa","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.E.C.","family":"Hallak","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.A.","family":"Moreira","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.S.","family":"Guimar\u00e3es","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","first-page":"34","article-title":"Marijuana in medicine: past, present and future","volume":"110","author":"Mikuriya TH","year":"1969","journal-title":"California Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0008-1264","issn-type":"print"},{"key":"ref2","series-title":"Cannabis and Cannabinoids","first-page":"37","volume-title":"History of cannabis in Western Medicine","author":"Fankhauser M","year":"2002"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0024-3205(99)00281-7","article-title":"Discovery and characterization of endogenous cannabinoids","volume":"65","author":"Martin BR","year":"1999","journal-title":"Life Sciences","ISSN":"https:\/\/id.crossref.org\/issn\/0024-3205","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/BF00402387","article-title":"Structure activity relationship of four tetrahydrocannabinols and the pharmacological activity of five semipurified extracts of Cannabis sativa","volume":"18","author":"Carlini EA","year":"1970","journal-title":"Psychopharmacologia","ISSN":"https:\/\/id.crossref.org\/issn\/0033-3158","issn-type":"print"},{"key":"ref5","series-title":"A comparative study on some chemical and biological characteristics of various samples of cannabis resin","first-page":"37","volume":"Bulletin on Narcotics 14","author":"Grlie L","year":"1976"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00432554","article-title":"Action of cannabidiol on the anxiety and other effects produced by delta9-THC in normal subjects","volume":"76","author":"Zuardi AW","year":"1982","journal-title":"Psychopharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0033-3158","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00428793","article-title":"Pharmacological interaction between cannabidiol and delta9-tetrahydrocannabinol","volume":"33","author":"Karniol IG","year":"1973","journal-title":"Psychopharmacologia","ISSN":"https:\/\/id.crossref.org\/issn\/0033-3158","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00429130","article-title":"Modification of delta9-THC-actions by cannabinol and cannabidiol in the rats","volume":"38","author":"Fernandes M","year":"1974","journal-title":"Psychopharmacologia","ISSN":"https:\/\/id.crossref.org\/issn\/0033-3158","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/cpt197518180","article-title":"Interactions in man of delta9-tetrahydrocannabinol, H-cannabinol and cannabidiol","volume":"18","author":"Hollister LE","year":"1975","journal-title":"Clinical Pharmacology and Therapeutics","ISSN":"https:\/\/id.crossref.org\/issn\/0009-9236","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0006-2952(81)90636-5","article-title":"Effect of cannabidiol on cytochrome P-450 and hexobarbital sleep time","volume":"30","author":"Bornhein LM","year":"1981","journal-title":"Biochemical Pharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0006-2952","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1476-5381.1972.tb08092.x","article-title":"A metabolic interaction in vivo between cannabidiol and delta9-tetrahydrocannabinol","volume":"45","author":"Jones G","year":"1972","journal-title":"British Journal of Pharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0007-1188","issn-type":"print"},{"key":"ref12","first-page":"453","article-title":"Effects of cannabidiol and delta9-tetrahydrocannabinol on operant behavior","volume":"9","author":"Davis WM","year":"1974","journal-title":"Research Communications in Chemical Pathology and Pharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0034-5164","issn-type":"print"},{"key":"ref13","first-page":"137","article-title":"Characteristics of the stimulus produced by the mixture of cannabidiol with D9-tetrahydrocannabinol","volume":"249","author":"Zuardi AW","year":"1981","journal-title":"Archives Internationales de Pharmacodynamie et de Therapie","ISSN":"https:\/\/id.crossref.org\/issn\/0003-9780","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0014-2999(74)90129-0","article-title":"Cannabidiol interferes with the effect of delta9-tetrahydrocannabinol in man","volume":"28","author":"Karniol IG","year":"1974","journal-title":"European Journal of Pharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0014-2999","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1007\/BF02085029","article-title":"Interactions of delta\u00b9-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man: Assay of cannabinol and cannabidiol by mass fragmentography","volume":"37","author":"Agurell S","year":"1981","journal-title":"Experientia","ISSN":"https:\/\/id.crossref.org\/issn\/0014-4754","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF00497858","article-title":"Hypnotic-like effects of cannabidiol in the rats","volume":"76","author":"Monti JM","year":"1977","journal-title":"Psychopharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0033-3158","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000137430","article-title":"Chronic administration of cannabidiol to healthy volunteers and epileptic patients","volume":"21","author":"Cunha J","year":"1980","journal-title":"Pharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0031-7012","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"8268","DOI":"10.1073\/pnas.95.14.8268","article-title":"Cannabidiol and delta9-tetrahydrocannabinol are neuroprotective antioxidants","volume":"95","author":"Hampson AJ","year":"1998","journal-title":"Proceedings of the National Academy of Sciences, USA"},{"key":"ref19","first-page":"12","article-title":"Pharmacological interaction of the effects of delta9-tetrahydrocannabinol and cannabidiol on serum corticosterone levels in rats","volume":"269","author":"Zuardi AW","year":"1984","journal-title":"Archives Internationales de Pharmacodynamie et de Therapie","ISSN":"https:\/\/id.crossref.org\/issn\/0003-9780","issn-type":"print"},{"key":"ref20","first-page":"213","article-title":"Effect of cannabidiol on plasma prolactin, growth hormone and cortisol in human volunteers","volume":"26","author":"Zuardi AW","year":"1993","journal-title":"Brazilian Journal of Medical and Biological Research","ISSN":"https:\/\/id.crossref.org\/issn\/0100-879X","issn-type":"print"},{"key":"ref21","first-page":"391","article-title":"Changes in the conditioned emotional response of rats induced by delta9-THC, CBD and mixture of the two cannabinoids","volume":"26","author":"Zuardi AW","year":"1983","journal-title":"Arquivos de Biologia e Tecnologia","ISSN":"https:\/\/id.crossref.org\/issn\/0365-0979","issn-type":"print"},{"key":"ref22","series-title":"Marihuana '84: Proceedings of the Oxford Symposium on Cannabis","first-page":"713","volume-title":"Anxiolytic properties of cannabidiol","author":"Musty RE","year":"1984"},{"key":"ref23","first-page":"1002","article-title":"Pharmacological characterization of cannabinoids in the elevated plus maze","volume":"253","author":"Onaivi ES","year":"1990","journal-title":"Journal of Pharmacology and Experimental Therapeutics","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3565","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF02244012","article-title":"Antianxiety effect of cannabidiol in the elevated plus-maze","volume":"100","author":"Guimar\u00e3es FS","year":"1990","journal-title":"Psychopharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0033-3158","issn-type":"print"},{"key":"ref25","first-page":"25","article-title":"Comparative effects between cannabidiol and diazepam on neophobia, food intake and conflict behavior","volume":"6","author":"Silveira Filho NG","year":"1981","journal-title":"Research Communications in Psychology, Psychiatry and Behavior","ISSN":"https:\/\/id.crossref.org\/issn\/0362-2428","issn-type":"print"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/026988119300700112","article-title":"Effects of ipsapirone and cannabidiol on human experimental anxiety","volume":"7","author":"Zuardi AW","year":"1993","journal-title":"Journal of Psychopharmacoly"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.npp.1300340","article-title":"Effects of cannabidiol (CBD) on regional cerebral blood flow","volume":"29","author":"Crippa JAS","year":"2004","journal-title":"Neuropsychopharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0893-133X","issn-type":"print"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0893-133X(00)00137-8","article-title":"To model a psychiatric disorder in animals: schizophrenia as a reality test","volume":"23","author":"Lipska BK","year":"2000","journal-title":"Neuropsychopharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0893-133X","issn-type":"print"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1503\/cmaj.1041064","article-title":"Modern antipsychotic drugs: a critical overview","volume":"172","author":"Gardner DM","year":"2005","journal-title":"Canadian Medical Association Journal","ISSN":"https:\/\/id.crossref.org\/issn\/0008-4409","issn-type":"print"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3109\/10673229609017200","article-title":"Brain dopamine receptors: a primer on their current status, basic and clinical","volume":"3","author":"Baldessarini RJ","year":"1996","journal-title":"Harvard Review of Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/1067-3229","issn-type":"print"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF02246184","article-title":"Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effects","volume":"120","author":"Hoffman DC","year":"1995","journal-title":"Psychopharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0033-3158","issn-type":"print"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/BF02244189","article-title":"Effects of cannabidiol in animal models predictive of antipsychotic activity","volume":"104","author":"Zuardi AW","year":"1991","journal-title":"Psychopharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0033-3158","issn-type":"print"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0006-3223(96)00546-X","article-title":"Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine","volume":"42","author":"Malhotra AK","year":"1997","journal-title":"Biological Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0006-3223","issn-type":"print"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ejphar.2005.02.040","article-title":"Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice","volume":"512","author":"Moreira FA","year":"2005","journal-title":"European Journal of Pharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0014-2999","issn-type":"print"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0306-4522(92)90054-6","article-title":"Neuroleptics increase c-Fos expression in the forebrain: contrasting effects of haloperidol and clozapine","volume":"46","author":"Robertson GS","year":"1992","journal-title":"Neuroscience","ISSN":"https:\/\/id.crossref.org\/issn\/0306-4522","issn-type":"print"},{"key":"ref36","series-title":"Cannabis and Cannabinoids: Pharmacology, Toxicology and Therapeutic Potential","first-page":"359","volume-title":"Cannabidiol: possible therapeutic application","author":"Zuardi AW","year":"2002"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.lfs.2004.01.015","article-title":"Cannabidiol increases Fos expression in the nucleus accumbens but not in the dorsal striatum","volume":"75","author":"Guimar\u00e3es VMC","year":"2004","journal-title":"Life Sciences","ISSN":"https:\/\/id.crossref.org\/issn\/0024-3205","issn-type":"print"},{"key":"ref38","series-title":"Cannabis in Medical Practice","first-page":"133","volume-title":"Cannabidiol as an anxiolytic and antipsychotic","author":"Zuardi AW","year":"1997"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0091-3057(91)90386-G","article-title":"Controlled clinical trial of cannabidiol in Huntington's disease","volume":"40","author":"Consroe P","year":"1991","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"key":"ref40","series-title":"Du Hachisch et de l'Alienation Mentale: Etudes Psychologiques","author":"Moreau JJ","year":"1845"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","article-title":"The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis","volume":"29","author":"D'Souza DC","year":"2004","journal-title":"Neuropsychopharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0893-133X","issn-type":"print"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0140-6736(82)91270-3","article-title":"Cannabis-associated psychosis with hypomaniac feature","volume":"2","author":"Rottanburg D","year":"1982","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0920-9964(00)00172-9","article-title":"Reduced binocular depth inversion in schizophrenic patients","volume":"53","author":"Schneider U","year":"2002","journal-title":"Schizophrenia Research","ISSN":"https:\/\/id.crossref.org\/issn\/0920-9964","issn-type":"print"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0091-3057(00)00201-X","article-title":"Different effects of nabilone and cannabidiol on binocular depth inversion in man","volume":"66","author":"Leweke FM","year":"2000","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans","volume":"51","author":"Krystal JH","year":"1994","journal-title":"Archives of General Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0003-990X","issn-type":"print"},{"key":"ref46","first-page":"A55","article-title":"Effects of cannabidiol on (s)-ketamine-induced psychopathology in healthy volunteers","volume":"17","author":"Bosi DC","year":"2003","journal-title":"Journal of Psychopharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0269-8811","issn-type":"print"},{"key":"ref47","first-page":"485","article-title":"Anti-psychotic effect of cannabidiol","volume":"56","author":"Zuardi AW","year":"1995","journal-title":"Journal of Clinical Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0160-6689","issn-type":"print"},{"key":"ref48","article-title":"Effect of cannabidiol in non responsive schizophrenia","author":"Zuardi AW","year":"2006","journal-title":"Journal of Psychopharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0269-8811","issn-type":"print"},{"key":"ref49","author":"Leweke FM","year":"2005"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/0269881105051541","article-title":"Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential","volume":"19","author":"Ashton CH","year":"2005","journal-title":"Journal of Psychopharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0269-8811","issn-type":"print"}],"container-title":["Brazilian Journal of Medical and Biological Research"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/bjmbr\/v39n4\/6164.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T01:35:33Z","timestamp":1555551333000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0100-879X2006000400001&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0100-879X2006000400001"],"URL":"https:\/\/doi.org\/10.1590\/s0100-879x2006000400001","relation":{},"ISSN":["0100-879X"],"issn-type":[{"value":"0100-879X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}